Register Now

Book your Hotel Now

Contact Us


News







Thematic Working Interest Groups (TWIGs)

Organizational Meetings Information


Plenary Speakers Announced

Dr. Samuel Stupp

Dr. George V. Ludwig

Dr. Kiran Masunuru




Important Dates:



Promotional Material:

Call for Abstracts Announcements: 4:3 | Widescreen

 






2017 Sponsors:

Gold

Burroughs Wellcome Fund


Silver

Wake Forest Institute for Regenerative Medicine (WFIRM)


Bronze

CELLINK

McGowan Institute of Regenerative Medicine at the University of Pittsburgh (MIRM)

PeproTech, Inc.

Tissue Source, LLC


Business Plan Competition Sponsor

BioLife Solutions


Pre-Conference Workshop Sponsor - Imaging and Assessment of Engineered Tissues

Perimed

MOLECUBES

O2M Technologies







2017 Exhibitors:

Advanced BioMatrix

Advanced Solutions Life Sciences

Allevi

Aptus Bioreactors

Aspect Biosystems Ltd.

Biomomentum Inc.

BioSpherix Medical

CELLINK

CellScale Biomaterials Testing

Evonik Corporation

Flexcell International Corporation

The Geneva Foundation

HypOxygen

International Institute for the Advancement of Medicine / IIAM

IOP Publishing

JPK Instruments AG

Kuraray Co. Ltd

LifeCore Biomedical

Mary Ann Liebert, Inc.

McGowan Institute for Regnerative Medicine at the Univeristy of Pittsburgh

MOLECUBES

Moor Instruments, Inc.

Nanoscience Instruments

NanoScribe GmbH

Nitta Gelatin

North Carolina Biotech Center

PeproTech Inc.

Perimed Inc.

Rees Scientific

Rheolution Inc.

ROKIT, Inc.

SERVA Electrophoresis GmbH

STEMCELL Technologies Inc.

Tissue Source, LLC

TissueByNet

University of Alberta / Banff Foundation for Allograft Pathology

Wake Forest Institute for Regenerative Medicine

 







Organized By:

TERMIS-AM Meeting is organized by the
Tissue Engineering & Regenerative Medicine International Society.

Call for Late Breaking Abstracts

SUBMIT Your Late Breaking Poster Abstract

Late Breaking Abstracts (Posters only): Opened

Deadline for Late Breaking Abstracts: September 18, 2017

Notification of Accepted Abstracts: September 25, 2017

Abstracts for poster only are invited for consideration for the Tissue Engineering & Regenerative Medicine International Society - Americas (TERMIS-AM) 2017 Conference and Exposition, December 3 – 6, 2017 at the Charlotte Convention Center in Charlotte, NC.

The TERMIS-AM 2017 Conference will feature an outstanding scientific program bringing together national and international communities of scientists, clinicians, industry leaders, post-doctoral fellows, graduate students entrepreneurs, and representatives of government funding agencies engaged in the fields of tissue engineering and regenerative medicine.

Abstract Consideration
Individuals from academia, industry and government are invited to present timely research findings in all areas of tissue engineering/regenerative medicine.

Abstracts submitters should choose one of the following categories:

  • Cardiovascular
  • Biomaterial scaffolds
  • Neuronal tissue
  • Matrix & extracellular matrix biology in regenerative medicine
  • Stem Cells
  • Musculoskeletal
  • Ophthalmology
  • Respiratory, Urologic and Gastrointestinal
  • Imaging
  • Cancer
  • Dental & Craniofacial
  • Regenerative Pharmacology
  • Skin & Wound Healing
  • Skin Regeneration and Immunomodulation
  • Soft tissue
  • Tissue chips & tissue organoid models
  • Production Assistance for Cellular Therapies
  • Biofabrication and Bioreactors
  • Commercialization of Regenerative Medicine Products
  • Regenerative Medicine Transplantation
  • Unlocking the potential of gelatin and collagen in regenerative medicine
  • Biobanking & Cryopreservation

    Review Criteria and Selection of Abstracts
    The most innovative and promising basic, applied and clinical research within the following topical areas will be considered for poster presentations. Abstracts based on new research that has not been presented or published elsewhere will be given primary consideration.
    Abstracts will be reviewed by members of the Program Planning Committee based on the following criteria:
  • Note:

    Abstract Content
    The abstract should clearly describe the nature of the research and the problem it addresses, and be presented in such language as to be understood by scientists representing the multi-disciplinary nature of tissue engineering. The abstract should summarize the objectives of the research, the methodology employed, results, and their significance.
    Content should be organized as follows:

    Abstract Preparation
    Authors must submit their abstract electronically by clicking on the link below: 

    Abstract Submission Site

    The ONLY option for selection is Late Breaking Poster abstract submission.

    Abstract Format

    Title: Title should be brief, clearly indicating the nature of the presentation. Title should be in bold font and mixed case font followed by a single return. Do not put a period at the end of the title.

        Example for Title: This is a Properly Formatted Abstract Title

    Author(s): In upper and lower case letters as follows: First Name, Middle Initial Last Name of each author (underline the name of the presenting author) with the corresponding institution of the author's. Follow with a single return.

    ** All abstract presenters are expected to pay their own travel expenses and conference registration fee(s).

    Complete contact information (name, mailing address, and e-mail) for each author listed on the abstract must be entered before submitting the abstract file.

    References: May be included at the end. Please use a standard format, such as that shown below: 

         References:
         1. Langer R, Vacanti JP. Tissue Engineering. Science 260, 920, 1993.

    Acknowledgments: Support from outside sources, such as Research Grants, should be listed here. Based on the standards set by the Accreditation Council for Continuing Medical Education and guidelines of the Food and Drug Administration as endorsed by the American Medical Association, any conflict of interest must be clearly recognizable. The indication of outside support does not affect the decision of abstract acceptance or rejection.

    Disclosures: Include any disclosure information here. In order for your colleagues to properly evaluate the information, analysis and opinions presented in your abstract, it is important that they be informed of potential conflicts of interest pertinent to the research submitted. Therefore, conference management requires that all authors provide any relevant information concerning personal or professional circumstances and relationships that might reasonably be expected to affect the author's view on the subject. Examples include, but are not limited to:

    Appropriate disclosure will be stated in the scientific program and the abstract volume. If you do not have anything to disclose, you must indicate this on the online abstract submission form. The disclosure information you provide will not influence the review of your abstract. Abstracts will not be reviewed without proper completion of the disclosure section on the abstract submission form. Disclosure information for all authors is required upon abstract submission.

    Online Revisions
    You may revise your abstract no later than 11:59 pm Eastern Standard Time on September 18, 2017, by returning to the site and logging in again. After the deadline, all completed abstracts in the system will be sent to the program committee for review. Any abstracts left "incomplete" will not be sent for review. There are no exceptions.

    Abstract Withdrawals
    If the abstract must be withdrawn, the TERMIS AM office must be notified in writing at least ONE month prior to the meeting via e-mail to Melanie Ryan, mryan@termis.org

    NOTE:
    Registration Requirements:
    All presenters are expected to cover their own travel and lodging expenses and pay the conference registration fees. Date of presentation cannot be guaranteed.

    For More Information

    For more information on abstract content, format and submission procedure, contact: 

    Melanie Ryan
    TERMIS-AM Meeting Manager
    mryan@termis.org